We are live on
!
Find out more
M&G plc Portfolio holdings
AUM
$20.1B
Turnover
14.5%
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
(-0.55%)
Cap. Flow
-$6.32M
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$811M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Intuit
INTU
|
+$152M |
| 4 |
Broadcom
AVGO
|
+$130M |
| 5 |
The Magnum Ice Cream Company N.V.
MICC
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$190M |
| 2 |
Elevance Health
ELV
|
+$109M |
| 3 |
CME Group
CME
|
+$92.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$79.9M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$67.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 16.38% |
| 3 | Consumer Discretionary | 15.42% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Southwest Airlines
LUV
$19.4B
| $17.4M | 0.09% |
457,469
-47,743
| -9% | -$2.16M |
2024 Q1
8 quarters
|
|
127
FMC
FMC
$894M
| $17M | 0.09% |
1,000,411
+11,041
| +1% | +$165K |
2025 Q4
1 quarter
|
|
128
Molson Coors Class B
TAP
$7.36B
| $16.5M | 0.09% |
384,404
+52,930
| +16% | +$2.51M |
2024 Q1
8 quarters
|
|
129
Ovintiv
OVV
$19.2B
| $16.4M | 0.08% |
+278,068
| New | +$13.4M |
2026 Q1
0 quarters
|
|
130
Sea Limited
SE
$57.8B
| $16.2M | 0.08% |
+195,140
| New | +$20.9M |
2026 Q1
0 quarters
|
|
131
Insmed
INSM
$21.2B
| $16.1M | 0.08% |
+98,221
| New | +$15.1M |
2026 Q1
0 quarters
|
|
132
Humana
HUM
$50.4B
| $15.7M | 0.08% |
90,712
+76,761
| +550% | +$15.7M |
2024 Q1
8 quarters
|
|
133
Intel
INTC
$477B
| $15.5M | 0.08% |
353,061
-107,312
| -23% | -$4.92M |
2024 Q1
8 quarters
|
|
134
Axsome Therapeutics
AXSM
$8.27B
| $15.4M | 0.08% |
91,339
+1,011
| +1% | +$175K |
2025 Q4
1 quarter
|
|
135
Everest Group
EG
$14.9B
| $15.3M | 0.08% |
46,843
+7,017
| +18% | +$2.31M |
2025 Q2
3 quarters
|
|
136
Pfizer
PFE
$168B
| $15.3M | 0.08% |
546,673
-30,507
| -5% | -$812K |
2024 Q1
8 quarters
|
|
137
Chevron
CVX
$441B
| $14.9M | 0.08% |
72,212
-67,740
| -48% | -$12.4M |
2024 Q1
8 quarters
|
|
138
Pony AI Inc
PONY
$2.15B
| $14.7M | 0.08% |
1,638,326
+1,194,169
| +269% | +$16.5M |
2025 Q4
1 quarter
|
|
139
Comcast
CMCSA
$77.9B
| $14.7M | 0.08% |
508,119
+64,239
| +14% | +$1.92M |
2024 Q1
8 quarters
|
|
140
Globant
GLOB
$1.7B
| $14.6M | 0.08% |
317,897
+218,337
| +219% | +$12.1M |
2025 Q4
1 quarter
|
|
141
PG&E
PCG
$39.2B
| $14.6M | 0.08% |
811,744
+12,455
| +2% | +$212K |
2025 Q1
4 quarters
|
|
142
Robinhood
HOOD
$88.7B
| $14.6M | 0.08% |
+211,202
| New | +$18.5M |
2026 Q1
0 quarters
|
|
143
TechnipFMC
FTI
$27.3B
| $14.4M | 0.07% |
+208,876
| New | +$12.6M |
2026 Q1
0 quarters
|
|
144
KLA
KLAC
$218B
| $14.4M | 0.07% |
+97,900
| New | +$14.3M |
2026 Q1
0 quarters
|
|
145
Hilton Worldwide
HLT
$77.7B
| $14.4M | 0.07% |
47,283
+503
| +1% | +$152K |
2025 Q3
2 quarters
|
|
146
Popular Inc
BPOP
$10.1B
| $14.3M | 0.07% |
106,873
+1,129
| +1% | +$151K |
2025 Q3
2 quarters
|
|
147
GE Vernova
GEV
$247B
| $14.1M | 0.07% |
+16,205
| New | +$12.6M |
2026 Q1
0 quarters
|
|
148
Highwoods Properties
HIW
$3.23B
| $14.1M | 0.07% |
673,617
+59,827
| +10% | +$1.44M |
2024 Q1
8 quarters
|
|
149
Mondelez International
MDLZ
$81.6B
| $14.1M | 0.07% |
242,956
+21,715
| +10% | +$1.26M |
2024 Q1
8 quarters
|
|
150
Baidu
BIDU
$27.3B
| $14M | 0.07% |
126,402
+38,306
| +43% | +$5.19M |
2024 Q1
8 quarters
|
|
Similar funds
SA
BBA
M&G plc's Q1 2026 Portfolio in Review
As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
- M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
- M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
- M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
- M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
- M&G plc opened 51 new positions and closed 43 in Q1 2026.
- M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.
Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.